New cancer drug trial seeks to control advanced tumors
Disease control
Recruiting now
This study is testing a new medicine, SNV4818, for people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The main goals are to find the safest and most effective dose of SNV4818, both by itself and when combined with other cancer drugs. Research…
Phase: PHASE1, PHASE2 • Sponsor: Pikavation Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC